Mark Miceli, DPM

  • Concord, NC
  • Primary podiatric medicine podiatrist
NPI1881678118PAC ID5991705733
Medicare patients, 2024
252
Part D claims, 2024
470
Industry payments
$114
Affiliated sites
1
Medical group
1
Practice address
1022 Lee-Ann NE Dr, Concord, NC 28025
Practice phone
Call (704) 786-4482
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Instride Foot and Ankle Specialists

Concord, North Carolina

See all 3 affiliations

Find Mark Miceli's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Mark Miceli is a primary podiatric medicine podiatrist in Concord, North Carolina

Mark Miceli practices at Instride Foot and Ankle Specialists in Concord, North Carolina.

Mark Miceli's NPI, 1881678118, was assigned on November 30, 2005. Mark Miceli graduated from Kent State University College of Podiatric Medicine in 1979. Mark Miceli holds North Carolina license 302.

NPI and contact details
Medicare PAC ID
5991705733
NPI enumeration date
November 30, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(704) 786-4482
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
73
Medical school graduation
1979

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Mark Miceli practices at Instride Foot and Ankle Specialists in Concord, North Carolina

Mark Miceli's primary practice is Instride Foot and Ankle Specialists, at 1022 Lee-Ann NE Dr, Concord, NC 28025 in Cabarrus County. The practice phone is (704) 786-4482.

  • Instride Foot and Ankle Specialists
    1022 Lee-Ann NE Dr, Concord, NC 28025 · Cabarrus CountyPhone(704) 786-4482

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Mark Miceli is affiliated with 2 sites of care and 1 medical group

Mark Miceli's primary practice is Instride Foot and Ankle Specialists in Concord, North Carolina. The medical group on file is InStride Foot & Ankle Specialists. Dmand AI also links Mark Miceli to 1 more group practice or clinic, named with a free account.

See all 3 affiliations for Mark Miceli

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Mark Miceli's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Miceli practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Instride Foot and Ankle SpecialistsAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Mark Miceli practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Mark Miceli is one of 74 primary podiatric medicine podiatrists in North Carolina

Primary podiatric medicine is Mark Miceli's primary specialty in the NPI Registry, under taxonomy code 213EP1101X. Mark Miceli is licensed in North Carolina.

Specialties and state licenses

  • Primary podiatric medicine podiatrist, North CarolinaPrimaryLicense 302 · taxonomy 213EP1101X

Primary podiatric medicine podiatrists near Mark Miceli

Counts of primary podiatric medicine podiatrists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Mark Miceli treated 252 Medicare patients in 2024, average age 72

CMS counts 252 Medicare patients who saw Mark Miceli in 2024. The largest group is 75 to 84, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Miceli's median patient age at 67, with 56% women.

Medicare patients, 2024252
Average age72
Average risk score1.70
Also on Medicaid37%

Mark Miceli's Medicare patients by age, 2024

Mark Miceli's Medicare patients by sex, 2024

  • Women12449%
  • Men12851%

Chronic conditions among Mark Miceli's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Diabetes58%
  4. Arthritis46%
  5. Chronic kidney disease39%
  6. Mood disorders33%
  7. Anxiety30%
  8. Depression30%

Share of Medicare patients with each condition. A patient can have several.

Mark Miceli's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women56%
  • Men44%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Mark Miceli wrote 470 Medicare Part D claims in 2024

In 2024, Mark Miceli wrote 470 Medicare Part D claims for 125 patients. 91% of them were for generic drugs.

Part D claims, 2024470
Part D patients125

Mark Miceli's Part D claims by kind of drug, 2024

  • Generic426 claims91%
  • Brand-name44 claims9%

Drug classes CMS tracks in Mark Miceli's Part D claims, 2024

  • Opioids8%36 of 470 claims
  • Antibiotics27%125 of 470 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Source: Medicare Part D Prescribers - by Provider (CMS), 2024 data

Mark Miceli ranks in the 83rd percentile for removal of tissue in Medicare

Mark Miceli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 81 procedures of removal of tissue by Mark Miceli, more than 83% of the clinicians it reports for that procedure.

Accepts Medicare assignment
Yes

Where Mark Miceli ranks in Medicare procedure volume

Removal of nail tissue
74th percentile188 procedures
Removal of tissue
83rd percentile81 procedures
Removal or shaving of skin growth
80th percentile56 procedures

CMS ranks each clinician against every clinician it reports for the same procedure category.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find primary podiatric medicine podiatrists like Mark Miceli by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Mark Miceli received $114 in industry payments in 2025

CMS Open Payments shows 6 general payments to Mark Miceli from 5 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Paratek Pharmaceuticals, Inc. paid the most, $28.

Companies that paid Mark Miceli the most, 2025 to 2025

Share is of all general payments to this clinician.

See all payments to Mark Miceli

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Mark Miceli graduated from Kent State University College of Podiatric Medicine

Mark Miceli graduated from Kent State University College of Podiatric Medicine in 1979.

  1. Medical schoolKent State University College of Podiatric Medicine

Source: Dmand AI Professional Profile Data

Sources for Mark Miceli's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Mark Miceli

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Mark Miceli's NPI number?

Mark Miceli's NPI number is 1881678118. It was assigned on November 30, 2005, and it is active in the NPI Registry.

What does Mark Miceli specialize in?

Mark Miceli is a primary podiatric medicine podiatrist in Concord, North Carolina. The primary specialty in the NPI Registry is Primary Podiatric Medicine Podiatrist (taxonomy code 213EP1101X).

Where does Mark Miceli practice?

Mark Miceli practices at 1022 Lee-Ann NE Dr, Concord, NC 28025. Mark Miceli's primary practice is Instride Foot and Ankle Specialists in Concord, North Carolina. Dmand AI also links Mark Miceli to 1 group practice or clinic.

What is Mark Miceli's office phone number?

The practice phone on file for Mark Miceli is (704) 786-4482.

What is Mark Miceli's medical license number?

Mark Miceli holds North Carolina license 302.

What medical group is Mark Miceli part of?

Mark Miceli is linked to InStride Foot & Ankle Specialists.

Does Mark Miceli accept Medicare?

Yes. CMS lists Mark Miceli as accepting Medicare assignment.

How many Medicare patients does Mark Miceli see?

CMS counts 252 Medicare patients who saw Mark Miceli in 2024, with an average age of 72.

Where did Mark Miceli go to medical school?

Mark Miceli graduated from Kent State University College of Podiatric Medicine in 1979.

Has Mark Miceli received payments from drug or device companies?

CMS Open Payments shows $114 in general payments to Mark Miceli from 5 companies from 2025 to 2025. The largest total came from Paratek Pharmaceuticals, Inc.

How long has Mark Miceli been practicing?

Mark Miceli graduated from medical school in 1979, 47 years ago.

Selling to primary podiatric medicine practices?

See primary podiatric medicine podiatrists in North Carolina by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)